On Tuesday, April 13, the FDA and CDC recommended pausing administration of the Johnson & Johnson COVID-19 vaccine. The recommendation was made after six women developed a rare type of blood clot. To date, 6.8 million doses of the Johnson & Johnson vaccination have been administered in the US, so the potential for an adverse event is rare. The type of complication is very rare, and the recommendation was made out of an abundance of caution. People who have received the Johnson & Johnson vaccination who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after the vaccination should contact your health care provider. The CDC and FDA are reviewing data involving the 6 cases and will provide additional information once their review is complete. We take your safety very seriously, and will continue to update you as more information is made available.
Dr. Tasha Starks
AMMC Family Physician
For more information on where you can receive the COVID-19 vaccine visit the Arkansas Department of Health website by clicking here: Arkansas Department of Health COVID-19 Vaccine Plan
Safety is a priority at Arkansas Methodist Medical Center (AMMC), and we are working harder than ever to make sure it remains a safe place to address ALL of your health care needs. In order to keep a healthy environment, we have updated our caregiver policy.
Patients may have 2 caregivers/visitors at a time, 4 designated to rotate in and out to visit with the following exceptions:
LABOR & DELIVERY
OUTPATIENT (Lab, X-ray, Cardiopulmonary, Surgery, etc.):
COVID POSITIVE PATIENTS:
Caregivers must meet COVID-19 screening criteria and follow AMMC guidelines. If a caregiver passes screening, they must wear a mask at all times.
The health of our community is important to everyone at AMMC. If you are experiencing mild to moderate COVID-19 symptoms, please call the AMMC hotline at 870-573-4223.
How to protect yourself and others
What you should know about COVID-19 to protect yourself and others
CDC's 10 ways to manage respiratory symptoms at home
How to home quarantine from the Arkansas Department of Health
CDC's steps to help prevent the spread of COVID-19 if you are sick
Arkansas Methodist Medical Center is proud to serve our community by offering the outpatient Covid-19 monoclonal antibody treatment, Bamlanivimab.
Bamlanivimab has received an emergency use authorization from the FDA for the treatment of active Covid-19 infections in non-hospitalized patients who meet specific “high risk” criteria.
If you have been diagnosed with Covid-19 you can speak with your healthcare provider to see if you qualify.
Bamlanivimab is a new drug and there is still much to learn about the benefits, risks, and side effects. Together, you and your healthcare provider can decide if treatment is right for you.